ClinicalTrials.gg
Not yet recruitingNCT06116487Updated Nov 3, 2023

MRI as Alternative to CBCT for the Assessment of Furcation Involvement in Molars

An observational study in Periodontitis, Periodontal Diseases and Furcation Defects, sponsored by Medical University of Vienna. Not yet recruiting at 1 site in Austria. Open to participants aged 18 Years to 120 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-03.

Sponsored by Medical University of Vienna · Observational

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
140
Ages
18 Years to 120 Years
Sex
All
01

Study summary

Aim of this prospective study is to compare magnetic resonance imaging (MRI) and cone beam computed tomography (CBCT) to diagnose furcation involvement (FI) in molars in patients with periodontitis. The focus is on the differentiation of grad II and III according to Hamp et al. 1975. 140 molars (70 upper and 70 lower) will be investigated with CBCT and MRI. Due to the absence of ionic radiation MRI might be a radiation free diagnostic tool to assess FI in the future without harmful radiation for the patient. Patients of the Dental Clinic, Medical University of Vienna, who need a CBCT and have a clinically diagnosed FI can be a participant of this clinical trial and do in addition to their CBCT a MRI. The accuracy of MRI will be compared to the diagnostic gold standard CBCT. If patients need additional periodontal treatment, e.g., periodontal surgery, a subgroup will also be analysed with intraoperative measurements.

02

Conditions studied

  • Periodontitis
  • Periodontal Diseases
  • Furcation Defects

Keywords

  • CBCT
  • MRI
  • Furcation involvement
03

In context

Periodontitis

1,231 studies on the registry are indexed under Periodontitis; 295 are open to participants now.

This study's planned enrollment of 140 is above the median of 90 across 372 observational studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Medical University of Vienna is the lead sponsor of 1,109 studies on the registry; 184 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 120 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with clinical detected furcation involvement at the first or second molars

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with FI grade II or III, patients who need a CBCT, not pregnant

Exclusion criteria

Exclusion Criteria:

  • Patients with to perform a MRI
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
140 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. horizontal furcation defects according to Hamp 1975

    Grad 0, I, II, III

    Time frame: day 1

Secondary outcomes

  1. horizontal bone loss

    measured in mm

    Time frame: day 1

  2. vertical bone loss

    measured in mm

    Time frame: day 1

07

Study locations

1 site
  • Medical University of Vienna, Clinic of Dentistry
    Vienna, 1090, Austria
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06116487
Responsible party
Elias Salzmann (Principal Investigator, Medical University of Vienna) — Principal investigator
First posted
Nov 3, 2023
Start date
Nov 20, 2023 (estimated)
Primary completion
Sep 20, 2024 (estimated)
Completion
Dec 20, 2024 (estimated)
Last update
Nov 3, 2023

Study contacts

Elias Salzmann
Contact
elias.salzmann@meduniwien.ac.at
0043 1 40070 4720

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion